What are the latest treatments for hepatitis C and why are they considered better than older methods?

Hepatitis C is a liver disease caused by the hepatitis C virus (HCV). It can lead to serious liver damage, including liver cancer and liver transplants. Traditionally, treating hepatitis C was challenging and involved painful shots of interferon and a pill called ribavirin. These treatments had severe side effects and only about 50% of patients were cured. However, recent advancements have made treatment much easier and more effective. Nowadays, many people can be cured by simply taking a pill at home for a few weeks. These new medications are called direct-acting antivirals (DAAs). They target the virus directly, preventing it from growing and spreading. Most people can get rid of the virus within 12 weeks, and the cure rates are much higher than older treatments. Some of the new drugs include Daclatasvir, Elbasvir, Grazoprevir, Glecaprevir, Pibrentasvir, Ledipasvir, Sofosbuvir, Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir, Simeprevir, Velpatasvir, and Voxilaprevir. Each of these drugs works in slightly different ways and may be used for different types of hepatitis C. The side effects of these new treatments are generally mild, such as headaches, fatigue, and stomach issues. It's important to discuss with your doctor which medication is best for you, as it depends on the type of hepatitis C you have and the condition of your liver. Research is ongoing, and new treatments continue to be developed, making it easier and safer to cure hepatitis C.